1. Home
  2. EVO vs MXL Comparison

EVO vs MXL Comparison

Compare EVO & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • MXL
  • Stock Information
  • Founded
  • EVO 1993
  • MXL 2003
  • Country
  • EVO Germany
  • MXL United States
  • Employees
  • EVO N/A
  • MXL N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • MXL Semiconductors
  • Sector
  • EVO Health Care
  • MXL Technology
  • Exchange
  • EVO Nasdaq
  • MXL Nasdaq
  • Market Cap
  • EVO 1.4B
  • MXL 1.2B
  • IPO Year
  • EVO 2021
  • MXL 2010
  • Fundamental
  • Price
  • EVO $4.15
  • MXL $15.06
  • Analyst Decision
  • EVO Strong Buy
  • MXL Buy
  • Analyst Count
  • EVO 1
  • MXL 7
  • Target Price
  • EVO $7.00
  • MXL $20.25
  • AVG Volume (30 Days)
  • EVO 42.9K
  • MXL 1.7M
  • Earning Date
  • EVO 11-05-2025
  • MXL 10-23-2025
  • Dividend Yield
  • EVO N/A
  • MXL N/A
  • EPS Growth
  • EVO N/A
  • MXL N/A
  • EPS
  • EVO N/A
  • MXL N/A
  • Revenue
  • EVO $912,894,891.00
  • MXL $423,372,000.00
  • Revenue This Year
  • EVO N/A
  • MXL $28.85
  • Revenue Next Year
  • EVO $10.78
  • MXL $17.69
  • P/E Ratio
  • EVO N/A
  • MXL N/A
  • Revenue Growth
  • EVO N/A
  • MXL 7.53
  • 52 Week Low
  • EVO $2.84
  • MXL $8.35
  • 52 Week High
  • EVO $5.64
  • MXL $25.73
  • Technical
  • Relative Strength Index (RSI)
  • EVO 63.61
  • MXL 42.30
  • Support Level
  • EVO $4.05
  • MXL $15.06
  • Resistance Level
  • EVO $4.27
  • MXL $18.40
  • Average True Range (ATR)
  • EVO 0.09
  • MXL 1.09
  • MACD
  • EVO 0.01
  • MXL -0.23
  • Stochastic Oscillator
  • EVO 73.91
  • MXL 3.22

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: